Consolidated Statements of Changes in Stockholders' (Deficit) Equity - USD ($)	Preferred Stock [Member] Series A Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Treasury Shares [Member]	Parent [Member]	Noncontrolling Interest [Member]	Total
Balance at Dec. 31, 2022	$ 140	$ 315,528	$ 179,015,250	$ (190,562,994)	$ (163,701)	$ (11,395,777)	$ (475,548)	$ (11,871,325)
Balance, shares at Dec. 31, 2022	1,400,000	31,552,775
Stock compensation expense		$ 9,785	12,479,558			12,489,343		12,489,343
Stock compensation expense, shares		978,500
Cashless exercise of stock options		$ 744	(744)
Cashless exercise of stock options, shares		74,372
Cashless exercise of warrants		$ 793	(793)
Cashless exercise of warrants, shares		79,330
Exercise of stock options		$ 375	94,125			94,500		94,500
Exercise of stock options, shares		37,500
Stock issued for noncontingent consideration payment		$ 10,689	2,557,311			2,568,000		2,568,000
Stock issued for noncontingent consideration payment, shares		1,068,926
Stock issued for legal settlement		$ 1,000	531,000			532,000		532,000
Stock issued for legal settlement, shares		100,000
Warrants issued with debt instrument			873,100			873,100		873,100
Sale of common stock under ATM, net		$ 10,099	6,192,560			6,202,659		6,202,659
Sale of common stock under ATM, net, shares		1,009,907
Stock issued for debt conversion		$ 6,720	993,280			1,000,000		1,000,000
Stock issued for debt conversion, shares		672,042
Common stock issued to Medifast		$ 12,244	9,987,756			10,000,000		10,000,000
Common stock issued to Medifast, shares		1,224,425
Series B Preferred Stock conversion		$ 15,609	5,057,205			5,072,814		5,072,814
Series B Preferred Stock conversion, shares		1,560,864
Series A Preferred Stock dividends				(3,106,250)		(3,106,250)		(3,106,250)
Distributions to non-controlling interest							(144,000)	(144,000)
Adjustment of membership interest in WorkSimpli			(229,025)			(229,025)	(76,600)	(305,625)
Net (loss) income				(20,595,992)		(20,595,992)	2,756,935	(17,839,057)
Balance at Dec. 31, 2023	$ 140	$ 383,586	217,550,583	(214,265,236)	(163,701)	3,505,372	2,060,787	5,566,159
Balance, shares at Dec. 31, 2023	1,400,000	38,358,641
Stock compensation expense		$ 16,100	12,218,697			12,234,797		12,234,797
Stock compensation expense, shares		1,609,960
Cashless exercise of stock options		$ 5,127	(5,127)
Cashless exercise of stock options, shares		512,777
Cashless exercise of warrants		$ 16,305	(16,305)
Cashless exercise of warrants, shares		1,630,458
Exercise of stock options		$ 863	119,449			120,312		120,312
Exercise of stock options, shares		86,250
Stock issued for noncontingent consideration payment		$ 958	641,042			642,000		642,000
Stock issued for noncontingent consideration payment, shares		95,821
Series A Preferred Stock dividends				(3,106,250)		(3,106,250)		(3,106,250)
Distributions to non-controlling interest							(773,888)	(773,888)
Net (loss) income				(18,881,732)		(18,881,732)	153,234	(18,728,498)
Balance at Dec. 31, 2024	$ 140	$ 422,939	$ 230,508,339	$ (236,253,218)	$ (163,701)	$ (5,485,501)	$ 1,440,133	$ (4,045,368)
Balance, shares at Dec. 31, 2024	1,400,000	42,293,907